Ergun S, Aslan S, Demir D, Kayaoglu S, Saydam M, Keles Y
Mol Diagn Ther. 2024; 28(4):403-423.
PMID: 38890247
PMC: 11211167.
DOI: 10.1007/s40291-024-00718-w.
Ren S, Zhang Z, Guo R, Wang D, Chen F, Chen X
World J Gastroenterol. 2023; 29(13):1911-1941.
PMID: 37155531
PMC: 10122790.
DOI: 10.3748/wjg.v29.i13.1911.
Jinesh G, Brohl A
Signal Transduct Target Ther. 2022; 7(1):296.
PMID: 35999218
PMC: 9399134.
DOI: 10.1038/s41392-022-01132-6.
Jinesh G, Napoli M, Smallin M, Davis A, Ackerman H, Raulji P
Sci Rep. 2021; 11(1):12673.
PMID: 34135394
PMC: 8209049.
DOI: 10.1038/s41598-021-91924-7.
Godwin I, Anto N, Bava S, Babu M, Jinesh G
Cell Death Discov. 2021; 7(1):80.
PMID: 33854056
PMC: 8047025.
DOI: 10.1038/s41420-021-00457-5.
Regulation of MYO18B mRNA by a network of C19MC miRNA-520G, IFN-γ, CEBPB, p53 and bFGF in hepatocellular carcinoma.
Jinesh G, Napoli M, Ackerman H, Raulji P, Montey N, Flores E
Sci Rep. 2020; 10(1):12371.
PMID: 32704163
PMC: 7378193.
DOI: 10.1038/s41598-020-69179-5.
Cancer Stem Cells: Emergent Nature of Tumor Emergency.
Efremov Y, Proskurina A, Potter E, Dolgova E, Efremova O, Taranov O
Front Genet. 2018; 9:544.
PMID: 30505319
PMC: 6250818.
DOI: 10.3389/fgene.2018.00544.
Chromosome 19 miRNA cluster and CEBPB expression specifically mark and potentially drive triple negative breast cancers.
Jinesh G, Flores E, Brohl A
PLoS One. 2018; 13(10):e0206008.
PMID: 30335837
PMC: 6193703.
DOI: 10.1371/journal.pone.0206008.
Apoptosis: A Target for Anticancer Therapy.
Pfeffer C, Singh A
Int J Mol Sci. 2018; 19(2).
PMID: 29393886
PMC: 5855670.
DOI: 10.3390/ijms19020448.
Molecular genetics and cellular events of K-Ras-driven tumorigenesis.
Jinesh G, Sambandam V, Vijayaraghavan S, Balaji K, Mukherjee S
Oncogene. 2017; 37(7):839-846.
PMID: 29059163
PMC: 5817384.
DOI: 10.1038/onc.2017.377.
Surface PD-L1, E-cadherin, CD24, and VEGFR2 as markers of epithelial cancer stem cells associated with rapid tumorigenesis.
Jinesh G, Manyam G, Mmeje C, Baggerly K, Kamat A
Sci Rep. 2017; 7(1):9602.
PMID: 28851898
PMC: 5575243.
DOI: 10.1038/s41598-017-08796-z.
RalBP1 and p19-VHL play an oncogenic role, and p30-VHL plays a tumor suppressor role during the blebbishield emergency program.
Jinesh G, Kamat A
Cell Death Discov. 2017; 3:17023.
PMID: 28580172
PMC: 5447132.
DOI: 10.1038/cddiscovery.2017.23.
Novel PKC-ζ to p47 phox interaction is necessary for transformation from blebbishields.
Jinesh G, Taoka R, Zhang Q, Gorantla S, Kamat A
Sci Rep. 2016; 6:23965.
PMID: 27040869
PMC: 4819220.
DOI: 10.1038/srep23965.